LINEPHARMA INTERNATIONAL LIMITEDActive
Key figures
LINEPHARMA INTERNATIONAL LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2023Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £1,500,000 (19% of the profit for the year).
Filed accounts2020–2023
| 2020 | 2023 | |
|---|---|---|
| Profit for the year | — | 7,879,804 |
| Cash at bank and in hand | 649,884 | 1,178,230 |
| Total assets | 7,575,417 | 18,373,749 |
| Total liabilities | 3,848,920 | 3,403,454 |
| Net assets / total equity | 2,977,201 | 14,970,295 |
| Average number of employees | 0 | 0 |
| Dividends paid | — | -1,500,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2023Distribution of pharmaceuiticals
As described in the company's latest filed accounts.
Summary: LINEPHARMA INTERNATIONAL LIMITED
Company
LINEPHARMA INTERNATIONAL LIMITED is a private limited company registered with Companies House under company number 08550018. It was incorporated on 30 May 2013. Its status is active. The registered office is in London (WC1H). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files small company accounts. Profit for the year was £7,879,804. Net assets were £14,970,295, up 402.8% on the previous year. Cash at bank and in hand was £1,178,230. Total assets were £18,373,749 and total liabilities £3,403,454. The company had an average of 0 employees. Figures are available for 2 financial years (2020–2023).
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 13 Jun 2027.